Plain-English translation of NCT07710729 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This research study is testing a new medication called to see if it is safe and works well when taken together with birth control tablets. The study will also measure how this medication affects how quickly your stomach empties food. Researchers want to make sure the medication doesn't interfere with how your body handles birth control or digestion.
is a new treatment being developed to help with weight management, but doctors need to understand how it interacts with other medications and your body's normal functions before it can be widely used. This study fills that gap by carefully testing these interactions in a controlled setting.
You likely qualify if…
You likely don't qualify if…
You will visit the research center multiple times over several weeks. During your visits, you will receive injections of the new medication under your skin, take birth control pills by mouth, and swallow a dose of (a common over-the-counter pain reliever) to help researchers measure your stomach function. The research team will take blood samples and monitor how your body responds to the medication.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Canada
Phase
Safety & dosing
Sponsor
Novo Nordisk A/S
Enrollment target
~40 participants
Started
July 2026
Primary completion
April 2027
Age range
18 Years – 65 Years
Sex
Female only
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Novo Nordisk
Novo Nordisk A/S
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.